1.3700
+0.0800
+(6.20%)
As of 8:22:54 PM GMT+1. Market Open.
Breakdown
TTM
4/30/2024
4/30/2023
Operating Expense
265.6250
265.6250
0.2340
Operating Income
-265.6250
-265.6250
-0.2340
Other Income Expense
-155.0290
-155.0290
--
Pretax Income
-420.6540
-420.6540
-0.2340
Net Income Common Stockholders
-420.6540
-420.6540
-0.2340
Diluted NI Available to Com Stockholders
-420.6540
-420.6540
-0.2340
Basic EPS
-0.01
-0.01
-0.00
Diluted EPS
-0.01
-0.01
-0.00
Basic Average Shares
38,475.0000
38,475.0000
38,475.0000
Diluted Average Shares
38,475.0000
38,475.0000
38,475.0000
Total Expenses
265.6250
265.6250
0.2340
Net Income from Continuing & Discontinued Operation
-420.6540
-420.6540
-0.2340
Normalized Income
-307.4828
-307.4828
-0.2340
EBIT
-265.6250
-265.6250
-0.2340
EBITDA
-265.6250
-265.6250
-0.2340
Net Income from Continuing Operation Net Minority Interest
-420.6540
-420.6540
-0.2340
Total Unusual Items Excluding Goodwill
-155.0290
-155.0290
--
Total Unusual Items
-155.0290
-155.0290
--
Normalized EBITDA
-110.5960
-110.5960
-0.2340
Tax Rate for Calcs
0.0003
0.0003
--
Tax Effect of Unusual Items
-41.8578
-41.8578
--
4/30/2023 - 1/2/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OVIT OncoVista Innovative Therapies, Inc.
0.0002
0.00%
TOVX Theriva Biologics, Inc.
1.2750
-0.39%
AVTX Avalo Therapeutics, Inc.
8.25
+4.37%
PCSA Processa Pharmaceuticals, Inc.
0.6410
-2.12%
ONCO Onconetix, Inc.
0.5545
-1.84%
CPRX Catalyst Pharmaceuticals, Inc.
22.55
-2.76%
BTAI BioXcel Therapeutics, Inc.
0.3181
-1.49%
DRUG Bright Minds Biosciences Inc.
33.20
+2.50%
BLRX BioLineRx Ltd.
3.4400
-3.64%
CERO CERo Therapeutics Holdings, Inc.
2.1400
+7.54%